GAYLE ELLIOTT: Open Payments
NPI 1861988537 · PINEVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$866 in 47 payments from 12 companies in 2025. Trend: 2023 $655 · 2024 $823 · 2025 $866
Food & beverage: $866
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 16 | $398 |
| ABBVIE INC. | 19 | $252 |
| Astellas Pharma US Inc | 2 | $34 |
| Amgen Inc. | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| Exact Sciences Corporation | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Corcept Therapeutics | 1 | $17 |
Products named: Auvelity, QULIPTA, VRAYLAR, Veozah, Cologuard Collection Kit, TRELEGY ELLIPTA, XIFAXAN, REPATHA.
Industry payments across LA — which companies pay providers there.
